August 02, 2019
1 min read

No correlation seen between preoperative narcotic use, patient satisfaction after spine surgery

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact

In patients who underwent elective spine surgery, no significant correlation was seen between preoperative narcotic use and perioperative adverse outcomes or hospitalization satisfaction scores, according to recently published results.

In a retrospective cohort study, researchers identified 346 patients who underwent elective spine surgery. Investigators assessed the NarxCare narcotics use score at the time of admission. Medical records were used to obtain patient characteristics, 30-day adverse events, readmissions, reoperations and morality. When available, the Hospital Consumer Assessment of Heath Care Providers and Systems survey data was obtained.

Patients were grouped based on ranges of admission NarxCare scores: 74 patients had a score of 0; 58 patients had a score of 1 to 99; 117 patients had a score of 300 to 499; and 21 patients had a score of 500 or more. The odds of adverse events, readmission, reoperation and mortality were compared between the narcotics groups with multivariate logistic regression. Survey response rates and results were compared between the different narcotics score groups with one-way ANOVA analysis.

Results from the multivariate logistic regressions did not detect statistically significant differences in the odds of adverse events, readmission, reoperation or mortality among the different groups of admissions narcotics scores. No statistically significant differences were seen between the survey response rates, total survey score or sub-group scores between the different narcotic score groups, according to analyses of variance results. – by Monica Jaramillo


Disclosures: The authors report no relevant financial disclosures.